Guided Therapeutics (GTHP) Change in Cash (2011 - 2026)

Guided Therapeutics has reported Change in Cash for 15 years, with the latest figure at -$24000.0 in Q4 2025.

• Quarterly Change in Cash fell 112.37% year-over-year to -$24000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$325000.0 (down 60.1% YoY) and the FY2025 annual result came in at -$325000.0, down 60.1% from the prior year.
• Change in Cash climbed to -$24000.0 in Q4 2025 per GTHP's latest filing, from -$98000.0 in the prior quarter.
• Over five years, Change in Cash peaked at $2.3 million in Q3 2022 and troughed at -$627000.0 in Q3 2023.
• A 5-year average of -$5950.0 and a median of -$143000.0 in 2023 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2022 and 2023: Change in Cash jumped 690.81% in 2022, then plunged 680.49% in 2023.
• Over 5 years, Change in Cash stood at $102000.0 in 2021, then slumped by 476.47% to -$384000.0 in 2022, then jumped by 63.54% to -$140000.0 in 2023, then jumped by 238.57% to $194000.0 in 2024, then tumbled by 112.37% to -$24000.0 in 2025.
• According to Business Quant data, Change in Cash over the past three periods registered -$24000.0, -$98000.0, and $70000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.